Ovintiv Inc. (NYSE:OVV - Free Report) - Equities researchers at Zacks Research boosted their Q1 2026 earnings per share estimates for shares of Ovintiv in a research note issued to investors on Tuesday, September 23rd. Zacks Research analyst Team now expects that the company will post earnings of $1.21 per share for the quarter, up from their previous estimate of $1.19. The consensus estimate for Ovintiv's current full-year earnings is $5.59 per share. Zacks Research also issued estimates for Ovintiv's Q2 2026 earnings at $1.05 EPS, Q3 2026 earnings at $1.12 EPS, Q4 2026 earnings at $1.40 EPS, FY2026 earnings at $4.78 EPS, Q1 2027 earnings at $1.32 EPS, Q2 2027 earnings at $1.34 EPS and FY2027 earnings at $5.85 EPS.
Ovintiv (NYSE:OVV - Get Free Report) last released its earnings results on Thursday, July 24th. The company reported $1.02 EPS for the quarter, missing analysts' consensus estimates of $1.04 by ($0.02). The firm had revenue of $1.79 billion during the quarter, compared to analysts' expectations of $1.92 billion. Ovintiv had a net margin of 6.46% and a return on equity of 14.24%.
Several other equities research analysts have also commented on the stock. Morgan Stanley set a $48.00 price objective on shares of Ovintiv and gave the stock an "equal weight" rating in a research note on Monday, August 18th. Wells Fargo & Company lowered their price objective on Ovintiv from $46.00 to $41.00 and set an "equal weight" rating for the company in a research note on Monday, June 16th. The Goldman Sachs Group raised Ovintiv from a "neutral" rating to a "buy" rating and increased their target price for the stock from $47.00 to $51.00 in a research note on Tuesday, July 1st. TD Cowen upgraded shares of Ovintiv to a "strong-buy" rating in a research note on Monday, July 7th. Finally, UBS Group lifted their target price on shares of Ovintiv from $51.00 to $52.00 and gave the stock a "buy" rating in a report on Wednesday, August 20th. Two investment analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, Ovintiv presently has an average rating of "Buy" and an average price target of $52.53.
View Our Latest Analysis on Ovintiv
Ovintiv Stock Performance
Shares of Ovintiv stock opened at $42.78 on Thursday. Ovintiv has a 12 month low of $29.80 and a 12 month high of $47.18. The firm has a market capitalization of $11.00 billion, a P/E ratio of 18.93, a P/E/G ratio of 5.37 and a beta of 1.08. The company has a current ratio of 0.43, a quick ratio of 0.43 and a debt-to-equity ratio of 0.42. The business has a fifty day simple moving average of $40.82 and a two-hundred day simple moving average of $38.91.
Institutional Trading of Ovintiv
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Concurrent Investment Advisors LLC grew its holdings in Ovintiv by 5.6% in the first quarter. Concurrent Investment Advisors LLC now owns 5,582 shares of the company's stock valued at $239,000 after purchasing an additional 297 shares during the period. Smartleaf Asset Management LLC grew its stake in shares of Ovintiv by 43.4% during the 1st quarter. Smartleaf Asset Management LLC now owns 1,154 shares of the company's stock valued at $49,000 after buying an additional 349 shares during the period. UMB Bank n.a. increased its holdings in shares of Ovintiv by 16.9% during the 1st quarter. UMB Bank n.a. now owns 2,890 shares of the company's stock worth $124,000 after buying an additional 417 shares during the last quarter. Crossmark Global Holdings Inc. raised its position in shares of Ovintiv by 0.6% in the 1st quarter. Crossmark Global Holdings Inc. now owns 69,212 shares of the company's stock worth $2,962,000 after buying an additional 420 shares during the period. Finally, ProShare Advisors LLC boosted its holdings in Ovintiv by 3.8% in the second quarter. ProShare Advisors LLC now owns 11,518 shares of the company's stock valued at $438,000 after acquiring an additional 427 shares during the last quarter. Hedge funds and other institutional investors own 83.81% of the company's stock.
Ovintiv Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 29th. Investors of record on Monday, September 15th will be issued a $0.30 dividend. The ex-dividend date of this dividend is Monday, September 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 2.8%. Ovintiv's dividend payout ratio (DPR) is presently 53.10%.
About Ovintiv
(
Get Free Report)
Ovintiv Inc, together with its subsidiaries, explores, develops, produces, and markets natural gas, oil, and natural gas liquids in the United States and Canada. The company operates through USA Operations, Canadian Operations, and Market Optimization segments. Its principal assets include Permian in west Texas and Anadarko in west-central Oklahoma; and Montney in northeast British Columbia and northwest Alberta.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ovintiv, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ovintiv wasn't on the list.
While Ovintiv currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.